Quantum-Si Incorporated (QSI)
NGM · Healthcare · Medical Devices
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About Quantum-Si Incorporated
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 591K | 552K | 451K | 258K |
| Gross Profit | 351K | 194K | 122K | 74K |
| Operating Income | -26.8M | -24.4M | -21.1M | -24.1M |
| Net Income | -28.8M | -35.7M | -17.6M | -21.7M |
| Diluted EPS | $-0.16 | $-0.17 | $-0.08 | $-0.10 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 1.1M | 3.1M | 2.4M |
| Gross Profit | 0.00 | 488K | 1.6M | 1.2M |
| Operating Income | -114.4M | -111.2M | -108.6M | -97.4M |
| Net Income | -132.4M | -96.0M | -101.0M | -101.3M |
| Diluted EPS | $-0.95 | $-0.68 | $-0.71 | $-0.51 |